Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase NA 1Phase 3 1

Status

Unknown 6Completed 6Recruiting 5Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Breast Neoplasms 1789Neoplasms 1516Carcinoma, Non-Small-Cell Lung 1053Prostatic Neoplasms 965Colorectal Neoplasms 889Lung Neoplasms 809Pancreatic Neoplasms 583Carcinoma, Hepatocellular 543Leukemia, Myeloid, Acute 540Stomach Neoplasms 523Ovarian Neoplasms 513Neoplasm Metastasis 492Multiple Myeloma 491Recurrence 417Melanoma 390Squamous Cell Carcinoma of Head and Neck 374Uterine Cervical Neoplasms 366Brain Neoplasms 364Head and Neck Neoplasms 355Esophageal Neoplasms 320Precursor Cell Lymphoblastic Leukemia-Lymphoma 313Endometrial Neoplasms 311Lymphoma 309Triple Negative Breast Neoplasms 301Glioblastoma 298Rectal Neoplasms 284Urinary Bladder Neoplasms 268Sarcoma 266Hematologic Neoplasms 266Colonic Neoplasms 257

Interventions

Radiosurgery 1Leuprolide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Advanced Prostate Cancer × Clear all
NCT06369246 2026-03-09

PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.

M.D. Anderson Cancer Center

Phase 1 Recruiting
70 enrolled
Genitourinary

Advanced Prostate Cancer

NCT06335914 2026-02-12

Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer

University Health Network, Toronto

Phase NA Recruiting
30 enrolled
Genitourinary

Advanced Prostate Cancer

NCT07115446 2025-12-05

Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate Cancer

Hansoh BioMedical R&D Company

Phase 1 Recruiting
63 enrolled
Genitourinary

Advanced Prostate Cancer

NCT05942001 2025-02-19

Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Recruiting
100 enrolled
Genitourinary

Advanced Prostate Cancer

NCT06490328 2024-07-08

Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer

Dongkook Pharmaceutical Co., Ltd.

Phase 3 Recruiting
154 enrolled
Genitourinary

Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡